José A Galván Selected Research

Cadherins (E-Cadherin)

1/2015

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José A Galván Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 01/2013
6	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2013
3	Inflammation (Inflammations) 01/2020 - 01/2013
2	Infections 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 07/2021 - 11/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2013
2	Carcinogenesis 01/2019 - 03/2017
2	Carcinoma (Carcinomatosis) 01/2017 - 04/2015
2	Adenocarcinoma 01/2016 - 11/2014
1	Rectal Neoplasms (Rectal Cancer) 06/2021
1	Esophageal Neoplasms (Esophageal Cancer) 05/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Kidney Neoplasms (Kidney Cancer) 11/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017
1	Hyperandrogenism 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Virilism (Virilization) 01/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2017
1	Monosomy 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 04/2015
1	Glioma (Gliomas) 04/2015
1	Keloid 04/2015
1	Lymphatic Metastasis 04/2015
1	Endotoxemia 06/2014
1	Pancreatitis 01/2013
1	Disease Progression 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Primitive Neuroectodermal Tumors (PNET) 01/2013
1	Neuroendocrine Carcinoma 01/2013
1	Celiac Disease (Celiac Sprue) 08/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 05/2014
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	VimentinIBA 01/2019 - 11/2014
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
2	Keratins (Keratin)IBA 01/2019 - 01/2019
2	EnzymesIBA 03/2017 - 01/2017
2	Dihydrotestosterone (Androstanolone)IBA 01/2017 - 01/2017
2	AndrogensIBA 01/2017 - 01/2017
2	SteroidsIBA 01/2017 - 01/2017
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Formaldehyde (Formol)FDA Link 07/2021
1	ParaffinIBA 07/2021
1	OligonucleotidesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Guanylate KinasesIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	ChromatinIBA 01/2019
1	G250 monoclonal antibodyIBA 11/2018
1	Carbonic Anhydrase IXIBA 11/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	trichostatin A (A 300)IBA 01/2018
1	theasinensin AIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Decitabine FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	LMK-235IBA 01/2018
1	Glycine Dehydrogenase (Decarboxylating)IBA 03/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016
1	TensinsIBA 01/2016
1	CollagenIBA 04/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2015
1	Cadherins (E-Cadherin)IBA 01/2015
1	ProcollagenIBA 11/2014
1	DesminIBA 11/2014
1	LipopolysaccharidesIBA 06/2014
1	CDX2 Transcription FactorIBA 05/2014
1	Peptide Hydrolases (Proteases)FDA Link 11/2013
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2013
1	Everolimus FDA Link 01/2013
1	Coloring Agents (Dyes)IBA 01/2013
1	AntibodiesIBA 01/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	HLA-DQ8 antigenIBA 08/2006
1	HLA-DQ Antigens (HLA-DQ)IBA 08/2006

Therapy/Procedure

2	Neoadjuvant Therapy 06/2021 - 05/2020
2	Therapeutics 01/2019 - 01/2013
2	Lasers (Laser) 01/2016 - 01/2015
1	Adjuvant Chemotherapy 07/2021
1	Castration 01/2017